DK159376C - Fremgangsmaade til fremstilling af et stabilt, fast, vandoploeseligt praeparat til rekonstituering med vand eller en vandig baerer som en stabil oploesning af 4'-(9-acridinylamino)methan-sulfon-m-anisid - Google Patents

Fremgangsmaade til fremstilling af et stabilt, fast, vandoploeseligt praeparat til rekonstituering med vand eller en vandig baerer som en stabil oploesning af 4'-(9-acridinylamino)methan-sulfon-m-anisid

Info

Publication number
DK159376C
DK159376C DK216681A DK216681A DK159376C DK 159376 C DK159376 C DK 159376C DK 216681 A DK216681 A DK 216681A DK 216681 A DK216681 A DK 216681A DK 159376 C DK159376 C DK 159376C
Authority
DK
Denmark
Prior art keywords
preparation
stable
water
acridinylamino
methan
Prior art date
Application number
DK216681A
Other languages
Danish (da)
English (en)
Other versions
DK216681A (da
DK159376B (da
Inventor
Murray Arthur Kaplan
Daniel Bouzard
Claude Perol
Jacques Stemer
Abraham Weber
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DK216681A publication Critical patent/DK216681A/da
Publication of DK159376B publication Critical patent/DK159376B/da
Application granted granted Critical
Publication of DK159376C publication Critical patent/DK159376C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK216681A 1980-05-16 1981-05-14 Fremgangsmaade til fremstilling af et stabilt, fast, vandoploeseligt praeparat til rekonstituering med vand eller en vandig baerer som en stabil oploesning af 4'-(9-acridinylamino)methan-sulfon-m-anisid DK159376C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14705680 1980-05-16
US06/147,056 US4360523A (en) 1980-05-16 1980-05-16 Pharmaceutical formulations of 4'-(9-acridinylamino)-methanesulfon-m-anisidide

Publications (3)

Publication Number Publication Date
DK216681A DK216681A (da) 1981-11-17
DK159376B DK159376B (da) 1990-10-08
DK159376C true DK159376C (da) 1991-03-25

Family

ID=22520148

Family Applications (1)

Application Number Title Priority Date Filing Date
DK216681A DK159376C (da) 1980-05-16 1981-05-14 Fremgangsmaade til fremstilling af et stabilt, fast, vandoploeseligt praeparat til rekonstituering med vand eller en vandig baerer som en stabil oploesning af 4'-(9-acridinylamino)methan-sulfon-m-anisid

Country Status (21)

Country Link
US (1) US4360523A (xx)
JP (1) JPS579716A (xx)
AT (1) AT374682B (xx)
AU (1) AU543726B2 (xx)
BE (1) BE888832A (xx)
CA (1) CA1160571A (xx)
CH (1) CH647677A5 (xx)
DE (1) DE3119510A1 (xx)
DK (1) DK159376C (xx)
FI (1) FI70793C (xx)
FR (1) FR2482458A1 (xx)
GB (1) GB2076288B (xx)
GR (1) GR75658B (xx)
IE (1) IE51285B1 (xx)
IT (1) IT1170970B (xx)
LU (1) LU83363A1 (xx)
NL (1) NL8102362A (xx)
NZ (1) NZ196985A (xx)
SE (1) SE460457B (xx)
YU (1) YU44831B (xx)
ZA (1) ZA813188B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4575509A (en) * 1983-01-31 1986-03-11 Bristol-Myers Company Water-soluble formulations of m-AMSA with pyroglutamic acid
US4626541A (en) * 1985-09-12 1986-12-02 Bristol-Myers Company Water soluble salt composition of m-AMSA
DE3844518A1 (de) * 1988-03-23 1989-10-05 Karl Heinz Dr Med Thiel Verwendung von aminochinolinen und aminopyridinen zur iontophoretischen behandlung maligner tumore
DE3819842C1 (xx) * 1988-03-23 1989-12-21 Karl Heinz Dr. 7100 Heilbronn De Thiel
CA2143515A1 (en) * 1994-03-22 1995-09-23 Prakash Parab Method for enhancing the rate of skin permeation of lactic acid through use of the l-enantiomer
WO2006002887A1 (en) * 2004-06-29 2006-01-12 Baxter International Inc. Aqueous drink solution of indibulin (d-24851) and an organic acid
DE102004031538A1 (de) * 2004-06-29 2006-02-09 Baxter International Inc., Deerfield Pharmazeutische Darreichungsform zur oralen Verabreichung eines schwerlöslichen Wirkstoffs, Verfahren zu deren Herstellung und Kit
EP1809279B1 (en) * 2004-11-08 2013-05-29 Baxter International Inc. Particulate compositions of tubulin inhibitor
EP2091532A1 (en) * 2006-11-28 2009-08-26 Ziopharm Oncology, Inc. Use of indolyl-3-glyoxylic acid derivatives including indibulin, alone or in combination with further agents for treating cancer
WO2015150383A1 (en) * 2014-03-31 2015-10-08 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Glycolic acid and/or d-lactic acid for the treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
SE460457B (sv) 1989-10-16
IT8148467A0 (it) 1981-05-14
DE3119510A1 (de) 1982-02-25
AT374682B (de) 1984-05-25
JPS579716A (en) 1982-01-19
FI70793C (fi) 1986-10-27
FR2482458B1 (xx) 1984-12-14
ZA813188B (en) 1982-05-26
NZ196985A (en) 1983-06-17
CA1160571A (en) 1984-01-17
BE888832A (fr) 1981-11-16
ATA221181A (de) 1983-10-15
JPH0136445B2 (xx) 1989-07-31
YU112381A (en) 1985-03-20
NL8102362A (nl) 1981-12-16
GR75658B (xx) 1984-08-02
DK216681A (da) 1981-11-17
SE8103071L (sv) 1981-11-17
US4360523A (en) 1982-11-23
CH647677A5 (de) 1985-02-15
GB2076288B (en) 1983-12-14
FR2482458A1 (fr) 1981-11-20
IT1170970B (it) 1987-06-03
IE51285B1 (en) 1986-11-26
FI811474L (fi) 1981-11-17
FI70793B (fi) 1986-07-18
DE3119510C2 (xx) 1991-03-07
LU83363A1 (fr) 1982-01-20
AU543726B2 (en) 1985-05-02
YU44831B (en) 1991-04-30
DK159376B (da) 1990-10-08
IE811092L (en) 1981-11-16
AU7029181A (en) 1981-11-19
GB2076288A (en) 1981-12-02

Similar Documents

Publication Publication Date Title
DK163637C (da) Fremgangsmaade til fremstilling af et stabilt, vandigt praeparat indeholdende ivermectin
DK204587D0 (da) Fremgangsmaade til fremstilling af et opbevaringsstabilt koncentrat, til fremstilling af et desinficeringsmiddel
NO812933L (no) Aminosyrederivater, fremgangsmaate til deres fremstilling, midler som inneholder forbindelsene samt deres anvendelse
DK515887A (da) Vandoploeselig, pulverformet formulering af glyphosat
DK404187D0 (da) Fremgangsmaade til fremstilling af thiazolderivater
DK86193D0 (da) Fremgangsmaade til fremstilling af trifluorbenzoesyrederivater
DK493083A (da) Fremgangsmaade til fremstilling af 4-oxo-1,4-dihydronicotinsyrederivater eller salte deraf
DK413783D0 (da) Fremgangsmade til fremstilling af 20-amino-macrolidderivater eller syreadditionssalte deraf
DK69382A (da) Fremgangsmaade til fremstilling af azepinderivater eller saltederaf
DK159376C (da) Fremgangsmaade til fremstilling af et stabilt, fast, vandoploeseligt praeparat til rekonstituering med vand eller en vandig baerer som en stabil oploesning af 4'-(9-acridinylamino)methan-sulfon-m-anisid
DK118578A (da) Fr&mgangsmaade til fremstilling af pyridinylaminoalkylethere,n-oxider eller physiologisk acceptable syreadditionssalte deraf
DK159079A (da) Fremgangsmaade til fremstilling af derivater af 4-amino-2-piperidinoquinazolin eller syreadditionssalte deraf
DK165790C (da) Fremgangsmaade til fremstilling af adriamycin-4'-o-derivater eller syreadditionssalte deraf
NO874355L (no) Fremgangsmaate for fremstilling av glycolipid som inneholder n-glycolylneuraminsyre.
DK321482A (da) Fremgangsmaade til fremstilling af 1-imidazolyl-2-phenyl-8-piperazinylphenoxy-octan-2-ol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK134580A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner eller syreadditionssalte deraf
DK164379A (da) Fremgangsmaade til fremstilling af 7-methoxy-5-oxo-5h-thiazolo(2,3-b)quinazolin-2-carboxylsyre eller farmaceutisk anvendelige salte deraf
DK430379A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner eller syreadditionssalte deraf
DK15282A (da) Fremgangsmaade til fremstilling af (+)-enantiomere eller (+)(-)-racemiske 4a,9b-trans-hexahydro-1h-pyridoindol-derivater eller farmaceutisk acceptable syreadditionssalte deraf
DK438482A (da) Fremgangsmaade til fremstilling af indanderivater eller syreadditionssalte deraf
DK146540C (da) Fremgangsmaade til fremstilling af alkaloider af leurosin-typen, eller syreadditionssalte deraf
DK586284D0 (da) Quinoloncarboxylsyre-derivater, fremgangsmaade til fremstilling deraf samt anvendelse af saadanne derivater som laegemiddel
DK553982A (da) Fremgangsmaade til fremstilling af omt-esterderivater eller syreadditionssalte deraf
DK340478A (da) Fremgangsmaade til fremstilling af dibenzo (d,g)-(1,3,6)dioxazocinderivater eller syreadditionssalte deraf
DK398283A (da) Fremgangsmaade til fremstilling af 1,4-dihydropyridinderivater eller farmaceutisk acceptable syreadditionssalte deraf